Skip to main content

Table 1 Clinical characteristics of patients reported with similar NEUROD2 variants

From: Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy

Characteristics

Sakpichaisakul et al., 2022 (this study)

Sega et al., 2019

Runge et al., 2021

NEUROD2 variant

c.388G > C, p. E130Q

c.388G > C, p. E130Q

c.388G > C, p. E130Q

Inheritance

De novo

De novo

De novo

Sex

Female

Female

Male

Birth weight (g), length (cm), head circumference (cm)

4500, 55, 36

3175, NA, NA

3175, 51.4, 31.8

Age at last examination

27 months

5 years

21 months

Weight, height, and head circumference at last examination

50th -75th, 50th, <3rd percentile

3rd –10th, 3rd, <3rd percentile

9.48 kg, 81.5 cm, 43.5 cm (<  1 percentile)

Failure to thrive

No

Yes

No

Onset of developmental delay (months)

2–4

2–4

NA

Onset of seizure (months)

5

5

4

Seizure type

Epileptic spasms

Epileptic spasms

Epileptic spasms

Initial EEG features

Multifocal epileptiform discharges

Hypsarrhythmia

NA

ASM previously tried

Vigabatrin, prednisolone, zonisamide

ACTH, prednisolone, pyridoxine, vigabatrin

NA

Seizure freedom

Yes, seizure free since the age of 22 months, currently on vigabatrin and zonisamide

Seizure free since the age of 2.5 years. Started on the ketogenic diet at 16 months, discontinued at 3 years

NA

Last EEG after being seizure-free

Intermittent epileptiform discharges over the bilateral posterior head regions.

Intermittent epileptiform discharges over the left temporal region and excessive slow waves over bilateral occipital regions during sleep, no electrographic seizures.

NA

Brain MRI features

At 6 months: increased T2/FLAIR signal intensity with restricted diffusion in bilateral globus pallidus. MRS: decreased NAA and presence of small lactate peak

At 24 months: symmetric hypersignal T2/FLAIR lesions without restricted diffusion in the central tegmental tract, delayed myelination in bilateral fronto-temporal lobes, and small right hippocampus.

At 6 months: delayed myelination and thin corpus callosum.

At 12 months: asymmetrical increased T2 signal intensity in

bilateral parietal white matter, thin corpus callosum, prominent

frontotemporal CSF spaces, improved myelination.

At 3.5 years: bilateral increased T2 signal intensities in

putamina, parietal periventricular white matter, diffuse thinning

of corpus callosum, normal myelination.

NA

Walking delay

Yes, currently stands alone, walks with support

Yes, still needs a walker

Most likely, yes (not yet)

Intellectual disability

Yes

Yes, severe cognitive dysfunction, is not able to understand simple commands

Yes

Speech disturbance

Yes, speaks one word

Yes, 5 single words only, no sentences

Yes, delayed

Autistic features/behavioral disorder

Yes, limited social interaction and repetitive behavioral patterns

NA

ASD

ADHD/aggressiveness

No

Yes, hyperkinetic movements

No

Physical exam features

Bilateral esotropia, anisocoria, repetitive hand and mouth movements

Bilateral esotropia, hyperkinetic movements

Microcephaly, hypotonia, global developmental delay, feeding difficulties, constipation

  1. Abbreviations: ADHD Attention-deficit hyperactive disorder, ASM Antiseizure medications, ASD Autism spectrum disorders, CBD Cannabidiol, FLAIR Fluid-attenuated inversion recovery, KD Ketogenic diet, NAA N-acetylaspartate, NA Not applicable